These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8275290)

  • 1. Hazards of fad diets in patients treated with ACE inhibitors.
    Sisodiya S; Hoffbrand BI
    Br J Hosp Med; 1993 Oct 20-Nov 2; 50(8):486-7. PubMed ID: 8275290
    [No Abstract]   [Full Text] [Related]  

  • 2. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Do we need more ACE inhibitors?].
    Haugen O
    Tidsskr Nor Laegeforen; 1990 Apr; 110(11):1411. PubMed ID: 2187274
    [No Abstract]   [Full Text] [Related]  

  • 4. Selenium-dependent GSH-Px in erythrocytes of patients with hypertension treated with ACE inhibitors.
    Djordjević VB; Grubor-Lajsić G; Jovanovic-Galović A; Pavlović D; Cvetković T; Pejović M; Lecić N
    J Environ Pathol Toxicol Oncol; 1998; 17(3-4):277-80. PubMed ID: 9726802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ACE inhibitors and cough].
    Kobayashi S; Kawakami Y; Hirabayashi T
    Kokyu To Junkan; 1990 Aug; 38(8):763-7. PubMed ID: 2218084
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
    Diadyk AI; Bagriĭ AE; Lebed' IA; Iarovaia NF; Shchukina EV; Gaĭdukov VO; Gritsenko PV; Diadyk IA
    Ter Arkh; 1997; 69(6):24-7. PubMed ID: 9297267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese.
    Woo KS; Nicholls MG
    Br J Clin Pharmacol; 1995 Aug; 40(2):141-4. PubMed ID: 8562296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibitors improve compliance.
    Gever LN
    Nursing; 1987 Oct; 17(10):143. PubMed ID: 2821461
    [No Abstract]   [Full Text] [Related]  

  • 9. Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.
    Bourgault C; Elstein E; Le Lorier J; Suissa S
    CMAJ; 1999 Aug; 161(3):255-60. PubMed ID: 10463046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Converting enzyme inhibitors in preterminal renal failure].
    Rambausek MH; Ritz E
    Dtsch Med Wochenschr; 1992 Jan; 117(2):77. PubMed ID: 1730207
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of lipid peroxides and antioxidative factors levels in blood of patients treated with ACE inhibitors.
    Djordjević VB; Pavlović D; Pejović M; Cvetković T; Lecić N; Deljanin-Ilić M
    Clin Nephrol; 1997 Apr; 47(4):243-7. PubMed ID: 9128791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C; Cosentino E; De Sanctis D
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
    Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):175-80. PubMed ID: 3030978
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
    Székács B; Vajo Z; Dachman W
    Acta Physiol Hung; 1996; 84(4):361-7. PubMed ID: 9328608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibitors.
    Aust Nurses J; 1988 Aug; 18(2):27-8. PubMed ID: 2848480
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring].
    Ruszty L; Hidas I; Iványi J; Dudás M; Molnár S
    Orv Hetil; 1996 Dec; 137(51):2851-4. PubMed ID: 9679620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
    Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.